Prelude Therapeutics
PRLD
58 hedge funds and large institutions have $162M invested in Prelude Therapeutics in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
8% more capital invested
Capital invested by funds: $150M → $162M (+$12.6M)
4% more funds holding
Funds holding: 56 → 58 (+2)
1.58% less ownership
Funds ownership: 63.88% → 62.29% (-1.6%)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
+$126K |
| 2 |
Renaissance Technologies
New York
|
+$110K |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$97.4K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$78.1K |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.17M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$985K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$561K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$392K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$255K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | -$27.2K | -6,987 | -77% |
|
52
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
| $7.09K | -$3.71K | -953 | -39% |
|
53
Legal & General Group
London,
United Kingdom
| $4.56K | – | – | – |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| $3.88K | – | – | – |
|
|
AB
55
Amalgamated Bank
New York
| $2K | -$2.06K | -530 | -61% |
|
|
HWM
56
HighMark Wealth Management
St. Paul,
Minnesota
| $237 | – | – | – |
|
|
AWM
57
Avior Wealth Management
Omaha,
Nebraska
| $4 | +$4 | +1 | New |
|
|
58
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$561K | -131,307 | Closed |
|
59
Squarepoint
New York
| – | -$126K | -29,418 | Closed |
|
|
VF
60
Virtu Financial
New York
| – | -$58K | -13,607 | Closed |
|
61
SG Americas Securities
New York
| – | -$56K | -13,100 | Closed |
|
62
Simplex Trading
Chicago,
Illinois
| – | -$261 | -67 | Closed |
|
63
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$8 | +2 | New |
|
PRLD Hedge Fund Activity: Q1 2024 in Review
58 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Prelude Therapeutics (PRLD) for Q1 2024, worth a combined $162M — up 8.4% from $150M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PRLD positions and 5 closed out — a net gain of 2 holders — while 16 added to existing stakes and 22 trimmed.
The largest buyer was Cerity Partners, opening a new position worth an estimated $126K. The largest seller was Morgan Stanley, cutting an estimated $1.17M.
- 58 institutional investors held Prelude Therapeutics (PRLD) as of Q1 2024, up from 56 in Q4 2023.
- Funds reported $162M of Prelude Therapeutics stock for Q1 2024, up 8.4% quarter-over-quarter.
- 7 funds opened new Prelude Therapeutics positions in Q1 2024 and 5 closed out, a net change of +2 holders.
- The largest Prelude Therapeutics buyer in Q1 2024 was Cerity Partners, an estimated $126K added.
- The largest Prelude Therapeutics seller in Q1 2024 was Morgan Stanley, an estimated $1.17M sold.
Based on aggregated 13F filings for Q1 2024.